ESR1 and breast carcinoma: TNBC is a highly aggressive and treatment-resistant breast cancer characterized by the absence/under-expression of three commonly targeted receptors: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor II (HER2).